期刊文献+

血清miRNA-21,miRNA-126表达在诊断PCI术后冠状动脉再狭窄的临床应用价值 被引量:12

Clinical Value of Serum miRNA-21 and miRNA-126 Expression in Diagnosis of the Coronary Artery Restenosis after PCI
下载PDF
导出
摘要 目的研究血清miRNA-21,miRNA-126检测在诊断经皮冠状动脉介入术(PCI)术后冠状动脉再狭窄(ISR)的临床应用。方法收集82例在泾阳县医院和陕西中医药大学附属医院接受PCI治疗的急性冠脉综合征(ACS)患者(狭窄组30例,未狭窄组52例)及33例体验健康者(对照组)的血清及临床资料,采用real-time qPCR技术检测血清中miRNA-21和miRNA-126的相对表达量,比较分析其在各组中的变化。应用血管内超声(intravascular ultrasound,IVUS)来评价PCI术后再狭窄的发生。结果血清miRNA-21和miRNA-126在对照组、未狭窄组和狭窄组中的表达量分别为(0.22±0.03,0.43±0.08,0.92±0.17)和(0.87±0.15,0.49±0.10,0.23±0.04)。与对照组比较,血清miRNA-21在狭窄组与未狭窄组的表达量明显增高,而miRNA-126表达水平则显著降低,差异均有统计学意义(P=0.000)。狭窄组与未狭窄组比较miRNA-21表达水平明显增高,而miRNA-126表达水平则显著降低,差异均有统计学意义(P=0.000)。IVUS结果显示,狭窄组的斑块面积(PLA)与未狭窄组比较显著增高,而最小管腔面积(MLA)显著降低,其差异均有统计学意义(P=0.000)。两标志物在狭窄组的表达量具有负相关性(r=-0.919,P<0.01)。狭窄组中miRNA-126和miRNA-21水平分别与PLA和MLA具有相关性(r=-0.945,0.926,P<0.01)和(r=0.933,-0.917,P<0.01)。结论血清miRNA-21和miRNA-126水平检测可用于急性冠脉综合征疾病PCI术后冠状动脉再狭窄的诊断以及预测,可能作为该疾病时的基因检测指标之一。 Objective To study the clinical application of serum miRNA-21 and miRNA-126 in diagnosis of the coronary artery restenosis after percutaneous coronary intervention(PCI).Methods The serum and clinical data of 82 cases of acute coronary syndrome(ACS)patients treated with PCI from the Hospital of Jingyang Country and the Affiliated Hospital of Shaanxi University of Chinese Traditional Medicine(stenosis group consisted of 30 cases,non-stenosis group consisted of 52 cases),and healthy persons(control group consisted of 33 cases)were collected.The relative expression levels of serum miRNA-21 and miRNA-126 were detected using real-time qPCR technology in the comparative analysis for their changes in the groups.Intravascular ultrasound(IVUS)was used to evaluate the occurrence of restenosis after PCI.Results Serum miRNA-21 and miRNA-126 levels in the control group,the non-stenosis group and the stenosis group were,,(0.22±0.03,0.43±0.08,0.92±0.17)and(0.87±0.15,0.49±0.10,0.23±0.04),respectively.Compared with the control group,the expression level of serum miRNA-21 in the stenosis group and the non stenosis group were significantly increased,while the miRNA-126 levels was significantly decreased(P=0.000),the differences were statistically significant.Compared with the non stenosis group,the level of miRNA-21 in the stenosis group was significantly increased,while the level of miRNA-126 was significantly decreased(P=0.000),the differences were statistically significant.The results of IVUS showed that the plaque area(PLA)of the patients in the stenosis group was significantly higher than that in the non stenosis group,while the minimal luman area(MLA)was significantly decreased,and the differences were statistically significant(P=0.000).There was a negative correlation between the expression of two markers in the stenosis group(r=-0.919,P〈0.01).The levels of miRNA-126 and miRNA-21 in the stenosis group were correlated with PLA and MLA(r=-0.945,0.926,P〈0.01)and(r=0.933,-0.917,P〈0.01).Conclusion The detection of serum miRNA-21 and miRNA-126 levels can be used in diagnosis and prediction for the coronary artary restenosis of ACS after PCI,as the gene detection index of the disease.
作者 程涛 黄刚 CHENG Tao;HUANG Gang(Departerment of Clinical Laboratory, the Hospital of Jingyang Country, Shaanxi Jingyang 713700, China;Department of Clinical Laboratory, the Affiliated Hospital of Shaanxi University of Chinese Traditional Medicine, Shaanxi Xianyang 712000,China)
出处 《现代检验医学杂志》 CAS 2018年第1期59-62,66,共5页 Journal of Modern Laboratory Medicine
  • 相关文献

参考文献9

二级参考文献106

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2051
  • 2Lopes RD, White JA, Tricoci P, et al. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coro- nary syndrome patients: insights from the EARLY ACS trial EJ]. Int J Cardiol, 2013,167(6) : 2580-2587.
  • 3Miller M,Cannon CP, Murphy SA, et al. Impact of triglycer- ide levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. [J]. J Am Coll Cardiol, 2008,51(7):724-730.
  • 4Yoo JY, Park CJ, Kim KY, et al. Development of an activated carbon filter to remove NO2 and HONO in indoor air[J]. J Hazard Mater, 2015,289:184-189.
  • 5van Diepen S, Bakal JA, Lin M, et al. Variation in critical care unit admission rates and outcomes for patients with acute coro- nary syndromes or heart failure among high- and low-volume cardiac hospitals [J]. J Am Heart Assoc,2015, 4(3) :e001708.
  • 6DOI M, NOS AKA K, MIYOSHI T, et al. Early eicosapentaenoicacid treatment after percutaneous coronary intervention reduces?acuteinflammatory responses and ventricular arrhythmias inpatients with acute myocardial infarction : A randomized, controlledstudy [J]. Int J Cardiol, 2014,176(3):577-582.
  • 7CHEN SL, SANTOSO T,ZHANG JJ. A randomized clinicalstudy comparing double kissing crush with provisional stentingfor treatment of coronary bifucation lesions [J], Am CollCardiol, 2011,57(8) :914-920.
  • 8ZOU JJ, XIE HG, CHEN SL, et al. Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascularevents in clopidogrel-treated Chinese patients underingpercutaneous coronary intervention [J]. Eur Clin pharmacol,2013,69(4):771-777.
  • 9KANG SJ,MINTZ GS,PARK DW, et al. Mechanisms ofin-stent restenosis after drug-eluting stent inpalntation :intravascular ultrasound analysis [J]. Circ Cardiovasc Inter,2011,4(1):9-14.
  • 10ONG PI, ATHANASIADIS A, PERNE A, et al. Coronaryvasomotor abnormalities in patients with stable angina aftersuccessful stent implantation but without in-stent restenosis [J].Clin Res Cardiol, 2014,103( 1) : 11-19.

共引文献85

同被引文献83

引证文献12

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部